Ignite Creation Date:
2025-12-26 @ 1:19 PM
Ignite Modification Date:
2026-01-04 @ 3:41 AM
Study NCT ID:
NCT02781506
Status:
TERMINATED
Last Update Posted:
2022-08-08
First Post:
2016-05-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell Carcinoma
Sponsor:
University of Texas Southwestern Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2021-05-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-05-24
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-19
First Submit QC Date:
None
Study First Post Date:
2016-05-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-04-29
Results First Submit QC Date:
None
Results First Post Date:
2022-08-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-12
Last Update Post Date:
2022-08-08
Last Update Post Date Type:
ACTUAL